Danaher Corp
NYSE:DHR

Watchlist Manager
Danaher Corp Logo
Danaher Corp
NYSE:DHR
Watchlist
Price: 231.112 USD 0.12%
Market Cap: 163.2B USD

Intrinsic Value

The intrinsic value of one DHR stock under the Base Case scenario is 195.989 USD. Compared to the current market price of 231.112 USD, Danaher Corp is Overvalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DHR Intrinsic Value
195.989 USD
Overvaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Danaher Corp

What is Valuation History?
Ask AI Assistant
What other research platforms think about DHR?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is DHR valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Danaher Corp.

Explain Valuation
Compare DHR to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Danaher’s heavy reliance on acquisitions to drive revenue growth poses integration and organizational complexity risks, potentially diluting value if synergy realization falls short of management’s targets.

Rising competition and increased consolidation within the life sciences and diagnostics sectors could pressure Danaher’s pricing power, especially as rivals expand their portfolios to match Danaher’s broad product lines.

A slowdown in research and development budgets at key customer segments, such as academic and biopharma labs, could weigh on Danaher’s revenue growth if global economic conditions worsen or governmental funding declines.

Bull Theses

Danaher’s disciplined M&A approach and strong track record of integrating acquisitions—underpinned by the Danaher Business System—have consistently improved operational efficiencies and enhanced product offerings.

Robust positions in high-growth areas like bioprocessing and molecular diagnostics grant Danaher pricing leverage and an expanding customer base, insulating it from slower-growing segments of the broader healthcare market.

Strong free cash flow generation and prudent capital deployment enable continued strategic acquisitions that bolster Danaher’s competitive moat and sustain above-average returns.

Show More Less
How do you feel about DHR?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Danaher Corp

Current Assets 9.6B
Cash & Short-Term Investments 1.5B
Receivables 4.7B
Other Current Assets 3.4B
Non-Current Assets 70.3B
PP&E 6.6B
Intangibles 61B
Other Non-Current Assets 2.7B
Current Liabilities 6.3B
Accounts Payable 1.7B
Accrued Liabilities 3B
Other Current Liabilities 1.6B
Non-Current Liabilities 22.5B
Long-Term Debt 16.8B
Other Non-Current Liabilities 5.7B
Efficiency

Free Cash Flow Analysis
Danaher Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Danaher Corp

Revenue
24.3B USD
Cost of Revenue
-9.8B USD
Gross Profit
14.5B USD
Operating Expenses
-9.7B USD
Operating Income
4.7B USD
Other Expenses
-1.2B USD
Net Income
3.5B USD
Fundamental Scores

DHR Profitability Score
Profitability Due Diligence

Danaher Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Healthy Operating Margin
Sustainable 3Y Average Operating Margin
50/100
Profitability
Score

Danaher Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

DHR Solvency Score
Solvency Due Diligence

Danaher Corp's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
High Interest Coverage
Low D/E
Long-Term Solvency
65/100
Solvency
Score

Danaher Corp's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DHR Price Targets Summary
Danaher Corp

Wall Street analysts forecast DHR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DHR is 263.263 USD with a low forecast of 222.2 USD and a high forecast of 325.5 USD.

Lowest
Price Target
222.2 USD
4% Downside
Average
Price Target
263.263 USD
14% Upside
Highest
Price Target
325.5 USD
41% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Dec 24, 2025
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for DHR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

DHR Insider Trading
Buy and sell transactions by insiders

DHR News

Other Videos
What is the Intrinsic Value of one DHR stock?

The intrinsic value of one DHR stock under the Base Case scenario is 195.989 USD.

Is DHR stock undervalued or overvalued?

Compared to the current market price of 231.112 USD, Danaher Corp is Overvalued by 15%.

Back to Top